Literature DB >> 12034448

Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein.

Heike Eberl1, Rudi Glockshuber.   

Abstract

Transmissible spongiform encephalopathies in mammals are believed to be caused by PrPSc, the insoluble, oligomeric isoform of the cellular prion protein PrPC. PrPC and the subunits of PrPSc have identical covalent but different tertiary structure. To address the question of whether parts of the structure of PrPC are sufficiently stable to be retained in PrPSc, we have constructed two deletion variants of the C-terminal PrPC domain, PrP(121-231), which is the only part of recombinant PrP with defined tertiary structure. One of the variants, H2-H3, comprises the last two alpha-helices of PrP(121-231) that have been proposed to be preserved in models of PrP(Sc). In the other variant, PrP(121-231)-deltaH1, the first alpha-helix of PrP(121-231) was deleted and replaced by introduction of the beta-turn dipeptide Asn-Gly between the strands of the single beta-sheet of PrP(121-231). Although both deletion constructs still show alpha-helical CD-spectra, they are more disordered and thermodynamically strongly destabilized compared to PrP(121-231), with free energies of folding close to zero. These data demonstrate that the tertiary structure context is critical for the conformation of the segment comprising alpha-helix 2 and 3 in the solution structure of recombinant PrP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034448     DOI: 10.1016/s0301-4622(02)00015-7

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  8 in total

1.  Coupled prediction of protein secondary and tertiary structure.

Authors:  Jens Meiler; David Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

2.  alpha-Helical domains promote translocation of intrinsically disordered polypeptides into the endoplasmic reticulum.

Authors:  Margit Miesbauer; Natalie V Pfeiffer; Angelika S Rambold; Veronika Müller; Sophia Kiachopoulos; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

3.  Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.

Authors:  Oxana Polyakova; Denise Dear; Igor Stern; Stephen Martin; Elizabeth Hirst; Suleman Bawumia; Angus Nash; Guy Dodson; Igor Bronstein; Peter M Bayley
Journal:  Eur Biophys J       Date:  2008-09-24       Impact factor: 1.733

4.  Structural features within the nascent chain regulate alternative targeting of secretory proteins to mitochondria.

Authors:  Natalie V Pfeiffer; Daniela Dirndorfer; Sven Lang; Ulrike K Resenberger; Lisa M Restelli; Charles Hemion; Margit Miesbauer; Stephan Frank; Albert Neutzner; Richard Zimmermann; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2013-03-12       Impact factor: 11.598

5.  The Sec61/SecY complex is inherently deficient in translocating intrinsically disordered proteins.

Authors:  Anika Gonsberg; Sebastian Jung; Sarah Ulbrich; Andrea Origi; Anke Ziska; Michael Baier; Hans-Georg Koch; Richard Zimmermann; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Biol Chem       Date:  2017-10-30       Impact factor: 5.157

6.  Role of the Disulfide Bond in Prion Protein Amyloid Formation: A Thermodynamic and Kinetic Analysis.

Authors:  Ryo Honda
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

7.  Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.

Authors:  Frédéric Eghiaian; Jeanne Grosclaude; Stéphanie Lesceu; Pascale Debey; Bénédicte Doublet; Eric Tréguer; Human Rezaei; Marcel Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

8.  Stability and conformational properties of doppel, a prion-like protein, and its single-disulphide mutant.

Authors:  Sheena M Whyte; Ian D Sylvester; Stephen R Martin; Andrew C Gill; Franziska Wopfner; Hermann M Schätzl; Guy G Dodson; Peter M Bayley
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.